Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1818501
Max Phase: Preclinical
Molecular Formula: C22H18F2N4O4S2
Molecular Weight: 504.54
Molecule Type: Small molecule
Associated Items:
ID: ALA1818501
Max Phase: Preclinical
Molecular Formula: C22H18F2N4O4S2
Molecular Weight: 504.54
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(/C=C2\SC(=S)NC2=O)cc1OCC(O)(Cn1cncn1)c1ccc(F)cc1F
Standard InChI: InChI=1S/C22H18F2N4O4S2/c1-31-17-5-2-13(7-19-20(29)27-21(33)34-19)6-18(17)32-10-22(30,9-28-12-25-11-26-28)15-4-3-14(23)8-16(15)24/h2-8,11-12,30H,9-10H2,1H3,(H,27,29,33)/b19-7-
Standard InChI Key: FUPHHJPASWRWGU-GXHLCREISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 504.54 | Molecular Weight (Monoisotopic): 504.0738 | AlogP: 3.02 | #Rotatable Bonds: 8 |
Polar Surface Area: 98.50 | Molecular Species: ACID | HBA: 9 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 4.93 | CX Basic pKa: 2.00 | CX LogP: 3.27 | CX LogD: 1.44 |
Aromatic Rings: 3 | Heavy Atoms: 34 | QED Weighted: 0.36 | Np Likeness Score: -1.32 |
1. Borate HB, Sawargave SP, Chavan SP, Chandavarkar MA, Iyer R, Tawte A, Rao D, Deore JV, Kudale AS, Mahajan PS, Kangire GS.. (2011) Novel hybrids of fluconazole and furanones: design, synthesis and antifungal activity., 21 (16): [PMID:21757344] [10.1016/j.bmcl.2011.06.022] |
Source(1):